3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
7
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
GATA2 Deficiency
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Cisplatin
4
Cetuximab
4
pembrolizumab
3
Radiotherapy
3
cemiplimab
2
Surveys and Questionnaires
2
Magnetic Resonance Spectroscopy
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
decitabine and cedazuridine drug combination
×
30 days
×
Clear all
No trials found.